AAAAAA
Results: 1-25/69
Authors:
KALECHMAN Y
GAFTER U
ALBECK M
SREDNI B
Citation: Y. Kalechman et al., DELAY IN THE ONSET OF SLE FOLLOWING TREATMENT WITH THE IMMUNOMODULATOR AS101 - ASSOCIATION WITH IL-10 INHIBITION AND INCREASE IN TNF-ALPHA LEVELS, European cytokine network, 9(3), 1998, pp. 45-45
Authors:
SHOHAT M
HODAK E
SREDNI B
SREDNI D
DAVID M
SHOHAT B
Citation: M. Shohat et al., IMMUNOMODULATION OF CYTOKINE PRODUCTION IN MYCOSIS-FUNGOIDES BY AS-101, European cytokine network, 9(3), 1998, pp. 315-315
Authors:
SHOHAT M
BENAMITAI D
SHOHAT B
SREDNI D
SREDNI B
DAVID M
Citation: M. Shohat et al., CYTOKINE PROFILE IN ATOPIC-DERMATITIS AND THE IMMUNOMODULATORY EFFECTOF AS-101, European cytokine network, 9(3), 1998, pp. 321-321
Authors:
GEFEN R
YADID G
SHALIT F
SREDNI B
Citation: R. Gefen et al., THE EFFECT OF THE IMMUNOMODULATOR AS101 ON PARKINSONS-DISEASE, European cytokine network, 9(3), 1998, pp. 351-351
Authors:
BREITBART E
KALECHMAN Y
SREDNI B
Citation: E. Breitbart et al., PREVENTION OF AGE-RELATED T-CELL APOPTOSIS DEFECT BY THE IMMUNOMODULATOR AS101 - ASSOCIATION WITH IL-10 INHIBITION AND INCREASE IN FAS EXPRESSION, European cytokine network, 9(3), 1998, pp. 352-352
Authors:
SREDNI B
STRASSMANN G
Citation: B. Sredni et G. Strassmann, THE IMMUNOMODULATOR AS101 INHIBITS IL-10 RELEASE AND AUGMENTS TNF-ALPHA AND IL-1-ALPHA RELEASE BY MOUSE AND HUMAN MONONUCLEAR PHAGOCYTES, European cytokine network, 9(3), 1998, pp. 449-449
Authors:
KALECHMAN Y
STRASSMANN G
ALBECK M
SREDNI B
Citation: Y. Kalechman et al., UP-REGULATION BY AMMONIUM TRICHLORO(DIOXOETHYLENE-0,0')TELLURATE (AS101) OF FAS APO-1 EXPRESSION ON B16 MELANOMA-CELLS - IMPLICATIONS FOR THE ANTITUMOR EFFECTS OF AS101/, The Journal of immunology (1950), 161(7), 1998, pp. 3536-3542
Authors:
ALBECK A
WEITMAN H
SREDNI B
ALBECK M
Citation: A. Albeck et al., TELLURIUM COMPOUNDS - SELECTIVE-INHIBITION OF CYSTEINE PROTEASES AND MODEL REACTION WITH THIOLS, Inorganic chemistry, 37(8), 1998, pp. 1704-1712
Authors:
ROSENBLATTBIN H
KALECHMAN Y
VONSOVER A
XU RH
DA JP
SHALIT F
HUBERMAN M
KLEIN A
STRASSMANN G
ALBECK M
SREDNI B
Citation: H. Rosenblattbin et al., THE IMMUNOMODULATOR AS101 RESTORES T-H1 TYPE OF RESPONSE SUPPRESSED BY BABESIA-RODHAINI IN BALB C MICE/, Cellular immunology (Print), 184(1), 1998, pp. 12-25
Authors:
KALECHMAN Y
GAFTER U
ALBECK M
SREDNI B
Citation: Y. Kalechman et al., SUPPRESSION OF INTERLEUKIN-10 BY THE IMMUNOMODULATOR AS101 INHIBITS DEVELOPMENT OF AUTOANTIBODIES AND GLOMERULONEPHRITIS IN SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE), Journal of the American Society of Nephrology, 8, 1997, pp. 2503-2503
Authors:
SHALIT F
SREDNI B
ROSENBLATTBIN H
KAZIMIRSKY G
BRODIE C
HUBERMAN M
Citation: F. Shalit et al., BETA-AMYLOID PEPTIDE INDUCES TUMOR-NECROSIS-FACTOR-ALPHA AND NITRIC-OXIDE PRODUCTION IN MURINE MACROPHAGE CULTURES, NeuroReport, 8(16), 1997, pp. 3577-3580
Authors:
SREDNI B
KALECHMAN Y
Citation: B. Sredni et Y. Kalechman, UP-REGULATION BY AS101 OF FAS (APO-1) EXPRESSION ON B16 MELANOMA-CELLS - IMPLICATIONS FOR THE ANTITUMOR EFFECTS OF AS101, Experimental hematology, 25(8), 1997, pp. 72-72
Authors:
KALECHMAN Y
CATANE R
ALBECK M
SREDNI B
Citation: Y. Kalechman et al., MECHANISM OF THE ANTITUMOR EFFECT OF THE IMMUNOMODULATOR AS101 AND PREVENTION BY AS101 OF BONE-MARROW TOXICITY WHEN ADMINISTERED WITH TAXOL, Experimental hematology, 25(8), 1997, pp. 550-550
Authors:
GAFTER U
SREDNI B
SEGAL J
KALECHMAN Y
Citation: U. Gafter et al., SUPPRESSED CELL-MEDIATED-IMMUNITY AND MONOCYTE AND NATURAL-KILLER-CELL ACTIVITY FOLLOWING ALLOGENEIC IMMUNIZATION OF WOMEN WITH SPONTANEOUSRECURRENT ABORTION, Journal of clinical immunology, 17(5), 1997, pp. 408-419
Authors:
GAFTER U
SREDNI B
SEGAL J
KALECHMAN Y
Citation: U. Gafter et al., IMMUNIZATION WITH WBC INDUCES MONOCYTE SUPPRESSION ACTIVITY IN-VITRO, Transplantation proceedings, 29(6), 1997, pp. 2649-2650
Authors:
GAFTER U
SREDNI B
SEGAL J
KALECHMAN Y
Citation: U. Gafter et al., IMMUNIZATION WITH WBC SUPPRESSES T-CELLS AND NK ACTIVITY IN-VITRO, Transplantation proceedings, 29(6), 1997, pp. 2703-2705
Authors:
KALECHMAN Y
GAFTER U
DA JP
ALBECK M
ALARCONSEGOVIA D
SREDNI B
Citation: Y. Kalechman et al., DELAY IN THE ONSET OF SYSTEMIC LUPUS-ERYTHEMATOSUS FOLLOWING TREATMENT WITH THE IMMUNOMODULATOR AS101 - ASSOCIATION WITH IL-10 INHIBITION AND INCREASE IN TNF-ALPHA LEVELS, The Journal of immunology, 159(6), 1997, pp. 2658-2667
Authors:
YEHUDA S
RABINOVITZ S
MOSTOFSKY DI
HUBERMAN M
SREDNI B
Citation: S. Yehuda et al., ESSENTIAL FATTY-ACID PREPARATION IMPROVES BIOCHEMICAL AND COGNITIVE FUNCTIONS IN EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS RATS, European journal of pharmacology, 328(1), 1997, pp. 23-29
Authors:
SREDNI B
TICHLER T
SHANI A
CATANE R
KAUFMAN B
STRASSMANN G
ALBECK M
KALECHMAN Y
Citation: B. Sredni et al., PREDOMINANCE OF TH1 RESPONSE IN TUMOR-BEARING MICE AND CANCER-PATIENTS TREATED WITH AS101, Journal of the National Cancer Institute, 88(18), 1996, pp. 1276-1284
Authors:
FISHMAN P
FALACHVAKNIN E
SREDNI B
MERONI PL
TINCANI A
DICKER D
SHOENFELD Y
Citation: P. Fishman et al., ASPIRIN-INTERLEUKIN-3 INTERRELATIONSHIPS IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME, American journal of reproductive immunology [1989], 35(2), 1996, pp. 80-84
Authors:
XU RH
KALECHMAN Y
ALBECK M
KUNG HF
SREDNI B
Citation: Rh. Xu et al., INHIBITION OF B16 MELANOMA METASTASIS BY THE IMMUNOMODULATOR AS101, International journal of oncology, 9(2), 1996, pp. 319-325
Authors:
SREDNI B
TICHLER T
SHANI A
SHAPIRA J
BRUDERMAN I
ALBECK M
KALECHMAN Y
Citation: B. Sredni et al., BONE-MARROW SPARING AND PREVENTION OF ALOPECIA BY AS101 IN A RANDOMIZED PHASE-II STUDY ON NSCL CANCER-PATIENTS TREATED WITH CARBOPLATIN ANDETOPOSIDE, Experimental hematology, 24(9), 1996, pp. 351-351
Authors:
KALECHMAN Y
TICHLER T
SHANI A
ALBECK M
SREDNI B
Citation: Y. Kalechman et al., DIFFERENTIAL EFFECT OF THE IMMUNOMODULATOR AS101 ON B7-1 AND B7-2 COSTIMULATORY MOLECULES - ROLE IN TH1 PREDOMINANCE AND IN THE ANTITUMORALEFFECTS OF AS101, Experimental hematology, 24(9), 1996, pp. 392-392
Authors:
DJALDETTI M
SREDNI B
ZIGELMAN R
VERBER M
FISHMAN P
Citation: M. Djaldetti et al., MUSCLE-CELLS PRODUCE A LOW-MOLECULAR-WEIGHT FACTOR WITH ANTICANCER ACTIVITY, Clinical & experimental metastasis, 14(3), 1996, pp. 189-196
PHOTOFRIN-II INDUCES CYTOKINE SECRETION BY MOUSE SPLEEN-CELLS AND HUMAN PERIPHERAL MONONUCLEAR-CELLS
Authors:
HERMAN S
KALECHMAN Y
GAFTER U
SREDNI B
MALIK Z
Citation: S. Herman et al., PHOTOFRIN-II INDUCES CYTOKINE SECRETION BY MOUSE SPLEEN-CELLS AND HUMAN PERIPHERAL MONONUCLEAR-CELLS, Immunopharmacology, 31(2-3), 1996, pp. 195-204